Keywords: first-quarter, results, strong, elan, irish, pharmaceutical, company
First-Quarter Results Strong From Elan
Article | 05 September 1994
The Irish pharmaceutical company Elan Corporation saw its pretax profits climb 24% to IL9.44 million ($14.5 million) in its fiscal first quarter. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
